These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 29157612)

  • 21. Pediatric TAFRO syndrome: A multi-institution case series illustrating clinical challenges and excellent outcomes.
    Johnson AK; Goteti S; Devald B; Mestnik S; Ghosh T; Williams R; Doughty ES; Linden MA; Beckman A; Williams T; Richardson K; Martinelli M
    Pediatr Blood Cancer; 2024 Oct; 71(10):e31234. PubMed ID: 39086111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S
    Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome.
    Sumiyoshi R; Koga T; Kawakami A
    Biomedicines; 2024 May; 12(6):. PubMed ID: 38927348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
    Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
    Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
    Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
    Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
    Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R
    Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report.
    Jilani RK; Saleem MR; Akhtar S; Jawad W
    Ann Hematol; 2024 Oct; ():. PubMed ID: 39400742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal case of TAFRO syndrome with unilateral adrenal hemorrhage in early-stage disease.
    Okamoto T; Ochi S; Motokawa Y; Azumi H; Kobayashi S; Nakamura F; Nakatani T; Yagi H
    J Clin Exp Hematop; 2021; 61(2):109-113. PubMed ID: 34092711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival.
    Gao YH; Liu YT; Zhang MY; Li SY; Fajgenbaum DC; Zhang L; Li J
    Br J Haematol; 2024 May; 204(5):1830-1837. PubMed ID: 38356434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.
    Rubenstein AI; Pierson SK; Shyamsundar S; Bustamante MS; Gonzalez MV; Milller ID; Brandstadter JD; Mumau MD; Fajgenbaum DC
    Br J Haematol; 2024 Mar; 204(3):921-930. PubMed ID: 38168727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.
    Zhou QY
    World J Clin Cases; 2022 Feb; 10(5):1536-1547. PubMed ID: 35211591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway.
    Sumiyoshi R; Koga T; Fukui S; Furukawa K; Momoki M; Ichinose K; Yano S; Kawakami A
    Clin Immunol; 2023 Nov; 256():109798. PubMed ID: 37778714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
    Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
    Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Castleman disease].
    Meignin V; Calvani J; Oksenhendler E
    Ann Pathol; 2023 Jan; 43(1):13-24. PubMed ID: 36192235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
    Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
    Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
    Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
    Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO.
    Phillips AD; Kakkis JJ; Tsao PY; Pierson SK; Fajgenbaum DC
    J Cell Mol Med; 2022 Jun; 26(11):3147-3152. PubMed ID: 35488725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.